RNXT
RNXT
NASDAQ · Biotechnology

Renovorx Inc

$1.01
+0.00 (+0.00%)
As of Apr 1, 3:50 PM ET ·
Analyst Consensus
Strong Buy
10
Analysts
Moderate
Coverage
Buy 9 90%
Hold 1 10%
Sell 0 0%
Price Target
Analyst Price Target +3,607.9% upside
Low Target $24.30
Average Target $37.45
High Target $44.03
Current Price $1.01
Current
$1.01
Target
$37.45
$24.30 $37.45 avg $44.03
Scenario Analysis
Bear Case
$24.30
2,305.9%
Low target
Base Case
$37.45
+3,607.9%
Avg target
Bull Case
$44.03
+4,259.4%
High target
Risk/Reward
1.8x
Balanced
Price in Context
52-Week High
$1.45
-30.3% from high
52-Week Low
$0.70
+44.2% from low
Target vs 52W High
$37.45
+2,482.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +19.8%
AMGN
Amgen Inc
Hold 42 50% $190.87 -46.0%
GILD
Gilead Sciences Inc
Strong Buy 38 79% $362.68 +158.5%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.0%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -90.1%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -68.9%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 -13.0%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -29.7%